Literature DB >> 18842581

Cyclooxygenase-2-derived prostaglandin E2 stimulates Id-1 transcription.

Kotha Subbaramaiah1, Robert Benezra, Clifford Hudis, Andrew J Dannenberg.   

Abstract

Cyclooxygenase-2 (COX-2) and Id-1 are overexpressed in a variety of human malignancies. Recently, each of these genes was found to play a role in mediating breast cancer metastasis to the lungs, but their potential interdependence was not evaluated. Hence, the main objective of the current study was to determine whether COX-2-derived prostaglandin (PGE(2)) activated Id-1 transcription, leading in turn to increased invasiveness of mammary epithelial cells. In MDA-MB-231 cells, treatment with PGE(2) induced Id-1, an effect that was mimicked by an EP(4) agonist. PGE(2) via EP(4) activated the epidermal growth factor receptor (EGFR) --> ERK1/2 pathway, which led to increased expression of Egr-1. PGE(2) stimulated EGFR signaling by inducing the release of amphiregulin, an EGFR ligand. The ability of PGE(2) to activate Id-1 transcription was mediated by enhanced binding of Egr-1 to the Id-1 promoter. Silencing of COX-2 or pharmacological inhibition of COX-2 led to reduced PGE(2) production, decreased Id-1 expression, and reduced migration of cells through extracellular matrix. A similar decrease in cell migration was found when Id-1 was silenced. The interrelationship between COX-2, PGE(2), Id-1, and cell invasiveness was also compared in nontumorigenic SCp2 and tumorigenic SCg6 mammary epithelial cells. Consistent with the findings in MDA-MB-231 cells, COX-2-derived PGE(2) induced Id-1, leading in turn to increased cell invasiveness. Taken together, these results suggest that PGE(2) via EP(4) activated the EGFR --> ERK1/2 --> Egr-1 pathway, leading to increased Id-1 transcription and cell invasion. These findings provide new insights into the relationship between COX-2 and Id-1 and their potential role in metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18842581      PMCID: PMC2662219          DOI: 10.1074/jbc.M805490200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

Review 1.  Cyclooxygenases: structural, cellular, and molecular biology.

Authors:  W L Smith; D L DeWitt; R M Garavito
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

2.  The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.

Authors:  G Steinbach; P M Lynch; R K Phillips; M H Wallace; E Hawk; G B Gordon; N Wakabayashi; B Saunders; Y Shen; T Fujimura; L K Su; B Levin; L Godio; S Patterson; M A Rodriguez-Bigas; S L Jester; K L King; M Schumacher; J Abbruzzese; R N DuBois; W N Hittelman; S Zimmerman; J W Sherman; G Kelloff
Journal:  N Engl J Med       Date:  2000-06-29       Impact factor: 91.245

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.

Authors:  R E Harris; G A Alshafie; H Abou-Issa; K Seibert
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

5.  TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

Authors:  D A Kujubu; B S Fletcher; B C Varnum; R W Lim; H R Herschman
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

6.  Host cyclooxygenase-2 modulates carcinoma growth.

Authors:  C S Williams; M Tsujii; J Reese; S K Dey; R N DuBois
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 7.  Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention.

Authors:  Andrew J Dannenberg; Scott M Lippman; Jason R Mann; Kotha Subbaramaiah; Raymond N DuBois
Journal:  J Clin Oncol       Date:  2005-01-10       Impact factor: 44.544

8.  Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines.

Authors:  D A Jones; D P Carlton; T M McIntyre; G A Zimmerman; S M Prescott
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

9.  Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice.

Authors:  H Sawaoka; S Kawano; S Tsuji; M Tsujii; E S Gunawan; Y Takei; K Nagano; M Hori
Journal:  Am J Physiol       Date:  1998-06

10.  Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester.

Authors:  R N DuBois; J Awad; J Morrow; L J Roberts; P R Bishop
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

View more
  15 in total

Review 1.  Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.

Authors:  Jocelyn Reader; Dawn Holt; Amy Fulton
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

2.  Small molecule inhibitors of the host cell COX/AREG/EGFR/ERK pathway attenuate cytomegalovirus-induced pathogenesis.

Authors:  Michael Melnick; George Abichaker; Khine Htet; Parish Sedghizadeh; Tina Jaskoll
Journal:  Exp Mol Pathol       Date:  2011-05-01       Impact factor: 3.362

3.  The role of PGE2-associated inflammatory responses in gastric cancer development.

Authors:  Hiroko Oshima; Masanobu Oshima
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

4.  Selective activation of the prostaglandin E2 circuit in chronic injury-induced pathologic angiogenesis.

Authors:  Elvira L Liclican; Van Nguyen; Aaron B Sullivan; Karsten Gronert
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-07-07       Impact factor: 4.799

5.  Prostaglandin E2 receptor 4 mediates renal cell carcinoma intravasation and metastasis.

Authors:  Yushan Zhang; Hamsa Thayele Purayil; Joseph B Black; Francis Fetto; Lauren D Lynch; Jude N Masannat; Yehia Daaka
Journal:  Cancer Lett       Date:  2017-01-17       Impact factor: 8.679

6.  Role of COX-2 in tumorospheres derived from a breast cancer cell line.

Authors:  Balraj Singh; Kendra R Cook; Laura Vincent; Carolyn S Hall; Cecilia Martin; Anthony Lucci
Journal:  J Surg Res       Date:  2010-03-26       Impact factor: 2.192

7.  Induction of Id-1 by FGF-2 involves activity of EGR-1 and sensitizes neuroblastoma cells to cell death.

Authors:  Giovanni Passiatore; Antonio Gentilella; Slava Rom; Marco Pacifici; Valeria Bergonzini; Francesca Peruzzi
Journal:  J Cell Physiol       Date:  2011-07       Impact factor: 6.384

8.  Epidermal growth factor-activated aryl hydrocarbon receptor nuclear translocator/HIF-1{beta} signal pathway up-regulates cyclooxygenase-2 gene expression associated with squamous cell carcinoma.

Authors:  Kwang-Yu Chang; Meng-Ru Shen; Mei-Yi Lee; Wen-Lin Wang; Wu-Chou Su; Wen-Chang Chang; Ben-Kuen Chen
Journal:  J Biol Chem       Date:  2009-02-09       Impact factor: 5.157

9.  Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma.

Authors:  Peter J Cook; Rozario Thomas; Philip J Kingsley; Fumiko Shimizu; David C Montrose; Lawrence J Marnett; Viviane S Tabar; Andrew J Dannenberg; Robert Benezra
Journal:  Neuro Oncol       Date:  2016-03-28       Impact factor: 12.300

10.  Id1 expression in endothelial cells of the colon is required for normal response to injury.

Authors:  Ning Zhang; Kotha Subbaramaiah; Rhonda K Yantiss; Xi Kathy Zhou; Yvette Chin; Ellen J Scherl; Brian P Bosworth; Robert Benezra; Andrew J Dannenberg
Journal:  Am J Pathol       Date:  2015-09-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.